Published in Rheumatology (Oxford) on January 01, 1999
Health economics: implications for novel antirheumatic therapies. Ann Rheum Dis (2005) 0.93
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Can different patient satisfaction survey methods yield consistent results? Comparison of three surveys. BMJ (1996) 3.20
Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. J Clin Microbiol (1997) 2.37
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Ann Oncol (2012) 2.16
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol (2000) 1.92
Presence of a hypermodified nucleotide in HeLa cell 18 S and Saccharomyces carlsbergensis 17 S ribosomal RNAs. FEBS Lett (1975) 1.92
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol (2000) 1.91
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Routine prenatal screening for HIV in a low-prevalence setting. CMAJ (1998) 1.61
Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J (1977) 1.55
The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia (2008) 1.49
Does waiting matter? A randomized controlled trial of new non-urgent rheumatology out-patient referrals. Rheumatology (Oxford) (2000) 1.48
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
Dupuytren's disease risk factors. J Hand Surg Br (2004) 1.41
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (1998) 1.35
The external transcribed spacer and preceding region of Xenopus borealis rDNA: comparison with the corresponding region of Xenopus laevis rDNA. Nucleic Acids Res (1983) 1.34
Interpreting self reported limiting long term illness. BMJ (1995) 1.32
High-resolution proton and carbon-13 NMR of membranes: why sonicate? Biochemistry (1987) 1.30
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Halothane biotransformation in man: a quantitative study. Anesthesiology (1967) 1.10
Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06
Treatment and survival on advanced breast cancer. Br Med J (1978) 1.04
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
Standard and non standard products in combined T(1) plus pancreatic RNAase fingerprints of HeLa cell rRNA and its precursors. FEBS Lett (1972) 0.99
A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess (2002) 0.99
Zinc increases phorbol ester receptors in intact B-cells, neutrophil polymorphs and platelets. FEBS Lett (1989) 0.98
FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke. Health Technol Assess (2006) 0.97
Acquired Brown's syndrome in systemic lupus erythematosus. Br J Rheumatol (1995) 0.96
Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96
Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) (1981) 0.94
Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93
Coxsackie B infection and arthritis. Br Med J (Clin Res Ed) (1983) 0.93
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol (1986) 0.92
Merkel cell carcinoma of the eyelid in association with chronic lymphocytic leukaemia. Br J Ophthalmol (2003) 0.91
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation. Diabetologia (2000) 0.90
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor. Ann Oncol (2005) 0.90
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Ann Oncol (1997) 0.89
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up. Ann Oncol (1994) 0.89
Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia (2004) 0.89
Two sequential randomized trials of community participation to recruit women for mammographic screening. Prev Med (1997) 0.88
A randomised controlled trial and economic evaluation of direct versus indirect and individual versus group modes of speech and language therapy for children with primary language impairment. Health Technol Assess (2007) 0.88
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer. Breast Cancer Res Treat (1997) 0.88
A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85
Systematic review of head cooling in adults after traumatic brain injury and stroke. Health Technol Assess (2012) 0.85
Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models. Diabetologia (2012) 0.85
Is chemotherapy for non-small cell lung cancer worthwhile? Lancet (1993) 0.85
Wegener's granulomatosis complicated by diabetes insipidus. Ann Rheum Dis (1983) 0.84
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1984) 0.84
Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. Ann Rheum Dis (1986) 0.84
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group. J Clin Oncol (1997) 0.83
Inhibition of epidermal growth factor binding to HeLa cells by auranofin. Biochem Pharmacol (1987) 0.83
Calcium ionophore A23187 enhances human neutrophil superoxide release, stimulated by phorbol dibutyrate, by converting phorbol ester receptors from a low- to high-affinity state. FEBS Lett (1987) 0.83
Epidemiology of acute drug intoxications: patient characteristics, drugs, and medical complications. Clin Toxicol (1974) 0.83
Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) (2003) 0.82
Quantifying the burden of emotional ill-health amongst patients referred to a specialist rheumatology service. Rheumatology (Oxford) (2003) 0.81
Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem Pharmacol (1990) 0.81
Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group. J Clin Oncol (1993) 0.81
Cervical spine surgery in patients with rheumatoid arthritis: an appraisal. Ann Rheum Dis (1996) 0.81
An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre. Br J Rheumatol (1995) 0.81
Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids. Ann Rheum Dis (1984) 0.81
Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model. Int J Clin Pharmacol Ther (2004) 0.80
IgG (kappa) paraproteinaemia and arthritis. Br J Rheumatol (1987) 0.80
An evaluation of the Health Assessment Questionnaire (HAQ) in a long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol (1994) 0.80
Effect of chloramphenicol and starvation for an essential amino acid on polypeptide and polyribonucleotide synthesis in Escherichia coli infected with bacteriophage T4. Arch Biochem Biophys (1975) 0.79
Corneal perforation in chronic graft-versus-host disease. Eye (Lond) (2001) 0.79
Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochem Pharmacol (1989) 0.78
Effects of piroxicam on superoxide generation, phospholipid methylation and leukotriene production by human blood mononuclear cells. J Rheumatol (1987) 0.78
Infection due to Staphylococcus warneri. Clin Infect Dis (1992) 0.78
Enhancement of protein kinase C-mediated EGF receptor phosphorylation by auranofin. Scand J Rheumatol (1988) 0.78
Transient presence in serum of an atypical alkaline phosphatase. Clin Chim Acta (1976) 0.78
Transcriptional control of T4 coliphage-specific genes 30, 42, 43, rIIA, rIIB, and e. J Gen Virol (1976) 0.78
Premature development of erosive osteoarthritis of hands in patients with chronic renal failure. Ann Rheum Dis (1990) 0.77
Re: Quality of life measures. Br J Rheumatol (1997) 0.77
Sjögren's syndrome, vasculitis, and cryoglobulinaemia associated with a monoclonal IgM (kappa) paraprotein with rheumatoid factor activity. Ann Rheum Dis (1987) 0.77
Drug resistance in clinical practice: patterns of treatment failure in patients receiving systemic therapy for advanced breast cancer. Eur J Cancer Clin Oncol (1987) 0.77
Differences in the association between childhood trauma and BMI in black and white South African women. Afr J Psychiatry (Johannesbg) (2013) 0.77
Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells). J Immunol (1987) 0.76
Reactive arthritis--infectious agents and genetic susceptibility in the pathogenesis of sero-negative arthritis. Scott Med J (1983) 0.76
The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis. Scand J Rheumatol Suppl (1987) 0.76
Sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford) (2000) 0.75
Screening for antimalarial maculopathy in rheumatology clinics. Br Med J (Clin Res Ed) (1985) 0.75
Diagnostic criteria for work-related upper limb disorders. Br J Rheumatol (1997) 0.75
Combination therapy in rheumatoid arthritis. Rheumatology (Oxford) (1999) 0.75
Re: Measuring outcomes in rheumatoid arthritis--which measures are suitable for routine use? Br J Rheumatol (1997) 0.75
Human fetal tissue from spontaneous abortions as potential sources of donor tissue for cell transplantation therapy. Transplant Proc (1994) 0.75
Routine follow up of breast cancer in primary care. More use should be made of specialist nurses. BMJ (1996) 0.75
Chondrosarcoma of the thyroid cartilage. J Laryngol Otol (1978) 0.75
The effects of anti-inflammatory and anti-rheumatic drugs on phagocyte cell function. Agents Actions Suppl (1988) 0.75
Changes in population distribution in Glasgow 1958-1975. Scott Geogr Mag (1979) 0.75